According to the May 1 2018 PR about advancing the closing documentation on the loan they were to receive 3,500,000 warrants priced at $1.30...at $4.00 those warrants are in the money to the tune of $2.70...that over $9.4 million right there, on top of the fees and interest payments. And if Apabetalone proves that it does everything this trial is hoping to prove it does...I would not be surprised if Resverlogix's MCap got up around $5 billion, which would be more than an 8 fold increase on the current MCap of around $600 million USD.
Looking forward to the trading tomorrow....g'night.
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
FEATURED Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • Mar 18, 2024 8:51 AM
FEATURED Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation • Mar 18, 2024 8:09 AM
Greenlite Ventures Enters into Strategic Alliance with Woodway USA • GRNL • Mar 15, 2024 4:00 PM
HealthLynked Welcomes David Rosal as New Chief Financial Officer • HLYK • Mar 13, 2024 8:00 AM
ECGI Holdings, Inc. Announces Continued Efforts in Financial Optimization • ECGI • Mar 13, 2024 8:00 AM
PSYC Begins Business Overhaul Process with Consolidation of 10 Previously Issued Convertible Debentures • PSYC • Mar 13, 2024 7:13 AM